Cannabis Watch: Cannabis company Curaleaf draws downgrade to hold at Benchmark, while Wedbush sticks to outperform

Benchmark flags cannabis market “uncertainty” while Wedbush sees “good start” to 2023 after Curaleaf beats revenue target, posts narrower-than-expected loss.

Previous post The Fed: Fed’s Williams says there is no evidence the era of very low ‘natural’ rates of interest has ended
Next post Bezos’ Blue Origin wins NASA astronaut moon lander contract to compete with SpaceX’s Starship